Obstetrics/Gynecology
RSSArticles
-
Recurrence Rate for Placental Abruption
A study from the Netherlands involving more than 1 million patients has shown that recurrence of placental abruption happens more frequently in those patients whose first abruption occurred at term and/or in their first pregnancy, as well as in those with a history of hypertension.
-
Hormone Replacement Therapy Controversies: Have We Harmed Women?
The interpretation of hormone replacement therapy in postmenopausal women has varied dramatically before and after the publication of the Women’s Health Initiative study in 2002. New studies question the validity of the conclusions reached by the investigators.
-
Molecular Diagnostics: A Step Forward in Breast Cancer Treatment?
Use of a gene-expression assay to predict prognosis may reduce the need for adjuvant chemotherapy in some women with early stage invasive breast cancer.
-
New Data on Atraumatic Tenaculum Pain Scores
ABSTRACT & COMMENTARY: There was no difference in pain scores between the standard single-tooth tenaculum and the atraumatic vulsellum tenaculum.
-
Congenital syphilis on rise — What you can do
Are you testing your pregnant patients for syphilis at the first prenatal visit and treating them if infected? If not, it’s time to step up your efforts. An analysis from the CDC shows that after years of decline, the number of congenital syphilis cases reported in the United States increased between 2012 and 2014.
-
Over-the-counter oral contraception is caught up in politics
Over the past several years, a small cadre of socially conservative policymakers and candidates, often hailing from swing states, have started to promote the idea of moving oral contraceptives over the counter as a supposed compromise in the political fight over contraception and, more broadly, reproductive health.
-
Get up to speed on ICD-10 coding for reproductive health services
While the purpose of ICD-10 is to improve clinical communication and accuracy, it will require more precise documentation of clinical care. Clinicians received vital tips on how to integrate the new coding in their family planning practices at the recent Contraceptive Technology Quest for Excellence conference in Atlanta.
-
Pills, patches, and rings — What’s the latest on the second-tier methods?
What are the benefits and disadvantages of such second-tier methods as pills, patches, and rings, and which women can safely use them? These Tier 2 methods, designated by their effectiveness ranking as adapted by the World Health Organization, depend on user behavior such as taking a pill every day or changing the patch or the ring on time.
-
Family planners can look into the future — What contraceptive options are in the pipeline?
What new methods can clinicians look to add to their arsenal of family planning options in the upcoming years? With the recent upsurge in interest in long-acting reversible contraceptives, it’s no surprise that several possible LARC options are moving through the research pipeline.
-
More women reported to be moving to long-acting reversible contraceptives
Results from two analyses of national data indicate that women are increasingly turning to use of long-acting reversible contraceptives such as the intrauterine device and implant for birth control.